Projected Growth of the Global Fentanyl Market to Reach $22.03 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the fentanyl market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Fentanyl Market By The End Of 2029?

The fentanyl market has experienced significant expansion in recent years. It is anticipated to increase from $16.22 billion in 2024 to $17.15 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.7%. Throughout the historic period, this expansion was driven by factors including pain management needs, medical procedures and surgeries, cancer pain management, the growth of the opioid analgesic market, and an aging population.

The fentanyl market is projected to experience robust expansion over the coming years. Its value is anticipated to reach $22.03 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.5%. This anticipated growth during the forecast period stems from a surge in chronic pain incidents, the proliferation of oncology treatments, an uptick in surgical interventions, various public health programs, and regulatory clearances for novel applications. Key trends identified for the forecast period encompass improvements in drug formulation technology, breakthroughs in detection methods, strategic public health and harm reduction efforts, an increase in pharmaceutical applications, and enhanced international cooperation and data exchange.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp

Which Business Drivers Are Underpinning The Growth Of The Fentanyl Market?

The rising occurrence of long-term health conditions is projected to boost the expansion of the fentanyl market in the future. These are health issues that endure for extended durations, typically exceeding three months, and frequently persist for a lifetime. Fentanyl’s primary application in such conditions is for the management of intense, ongoing pain that other treatments cannot adequately alleviate. An example illustrating this trend comes from October 2024: data from the Heart Disease Facts, published by the Centers for Disease Control and Prevention (CDC), a US-based public health agency, indicated that in the United States, coronary heart disease (CHD) caused 371,506 fatalities in 2022. This contributed to a total of 702,880 heart disease deaths, representing approximately 1 in every 5 deaths. Consequently, the growing incidence of chronic illnesses is a key factor propelling the expansion of the fentanyl market.

What Are The Principal Segment Types In The Fentanyl Market?

The fentanyl market covered in this report is segmented –

1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)

2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain

3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations

2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch Systems

How Are Industry Trends Steering The Expansion Of The Fentanyl Market?

Leading companies operating in the fentanyl market are developing innovative products such as Opvee and obtaining approvals to serve broader customer bases, increase sales, and boost revenue. Opvee (nalmefene) is a potent opioid receptor blocker utilized for addressing known or suspected opioid overdoses induced by natural or synthetic opioids like fentanyl. For example, in May 2023, Indivior PLC, a US-based pharmaceutical company, secured U.S. Food and Drug Administration approval for Opvee nasal spray. Its mechanism involves preventing the effects of opioids on the brain, which can assist patients who have recently overdosed in restoring their respiration and blood pressure to normal levels. Opvee is administered as a nasal spray, facilitating ease of use during emergencies. It is a vital component in the array of medications employed to combat opioid overdoses and save lives.

Which Companies Are Contributing Significantly To The Fentanyl Market Growth?

Major companies operating in the fentanyl market report are Pfizer Inc., Johnson & Johnson, Sinopharm Group, Merck & Co. Inc., Bayer AG, Novartis AG, Kyowa Kirin Co. Ltd., Fresenius Kabi Oncology Ltd., Abbott Laboratories, Sanofi S.A, Boehringer Ingelheim GmbH, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, AstraZeneca PLC, Apotex Inc., Hisamitsu Pharmaceutical Co. Inc., Alvogen, Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Insys Therapeutics Inc., Exela Pharma Sciences LLC, Paladin Labs Inc., Bryant Ranch Prepack Inc., Galena Biopharma Inc., Validus Pharmaceuticals LLC, Quality Care Products LLC, Dispensing Solutions Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

Which Region Offers The Most Opportunity For Fentanyl Market Expansion?

North America was the largest region in the fentanyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=13237&type=smp

Browse Through More Reports Similar to the Global Fentanyl Market 2025, By The Business Research Company

Alopecia Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/alopecia-global-market-report

Hemophilia Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemophilia-global-market-report

Pheochromocytoma Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pheochromocytoma-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795